HomeINTI • OTCMKTS
add
Inhibitor Therapeutics Inc
Previous close
$0.088
Year range
$0.013 - $0.30
Market cap
15.14M USD
Avg Volume
7.07K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.27M | 200.56% |
Net income | -1.17M | -109.44% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.84M | -26.03% |
Total assets | 8.95M | -25.27% |
Total liabilities | 3.67M | -0.37% |
Total equity | 5.28M | — |
Shares outstanding | 172.02M | — |
Price to book | 2.93 | — |
Return on assets | -34.31% | — |
Return on capital | -54.25% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.17M | -109.44% |
Cash from operations | -697.71K | -105.86% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -697.71K | -105.86% |
Free cash flow | -326.24K | 52.69% |
About
Founded
1992
Headquarters
Website
Employees
6